Articles by : William Newton, Associate Editor/Senior Writer

Exclusive

Arkansas Plans to Challenge J&J’s Contested 340B Rebate Proposal for Violation of State Law

September 10, 2024 William Newton, Associate Editor/Senior Writer Views

J&J said its 340B rebate proposal will apply to Arkansas covered entities.

Arkansas plans to challenge Johnson & Johnson’s (J&J’s) 340B rebate proposal for violating the state’s law barring drugmaker contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

In Another Drug Industry Setback, Maryland Federal Judge Rejects Bids to Block State’s 340B Contract Pharmacy Access Law

September 10, 2024 William Newton, Associate Editor/Senior Writer Views

A federal district judge in Maryland denied multiple drug industry motions in a contract pharmacy lawsuit.

A Maryland federal district judge has denied four separate drug industry attempts to block the state’s contract pharmacy access law—marking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HHS Asks D.C. Federal Court to Rule for Drugmakers in Contract Pharmacy Lawsuits, Ties Outcomes to Kalderos 340B Rebate Case

September 6, 2024 William Newton, Associate Editor/Senior Writer Views

HHS filed status reports in five separate ongoing drug industry cases before a federal district court.

The U.S. government is asking a federal district court in Washington, D.C., to rule for drugmakers in four separate lawsuits [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck Offers Refunds to 340B Providers for Overcharges of Inhaler in Fourth Notice This Year

September 6, 2024 William Newton, Associate Editor/Senior Writer Views

Drugmaker Merck announced it will refund 340B covered entities for certain overcharges.

Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J’s 340B Rebate Vendor to Host In-Person Training Next Monday Despite Government’s Objection to Proposal

September 4, 2024 William Newton, Associate Editor/Senior Writer Views

Beacon Channel Management is holding multiple trainings on its 340B rebate platform.

The new industry vendor administrating Johnson & Johnson’s (J&J’s) contested 340B rebate proposal is hosting an in-person training for third [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

UPDATED: Certain NDCs for Four of Ten Newly Announced Medicare Negotiated Drug Prices Are Below Current 340B Prices

September 4, 2024 William Newton, Associate Editor/Senior Writer Views

CMS announced the "maximum fair price" for the first ten drugs selected for Medicare drug price negotiations.

Certain formulations for four of the first ten drugs selected for Medicare drug price negotiations have newly negotiated prices lower [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Hospital Groups Urge HRSA to Take ‘Immediate Enforcement Action’ Against J&J’s Contested 340B Rebate Proposal

August 29, 2024 William Newton, Associate Editor/Senior Writer Views

Two major hospital groups urged the government to take enforcement action against J&J's 340B rebate proposal.

Two major hospital advocacy groups are urging the federal agency that oversees the 340B program to “take immediate enforcement action” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Judge Calls Astra Subpoenas ‘Overly Broad,’ Mo. Officials Push to Dismiss Lawsuit

August 29, 2024 William Newton, Associate Editor/Senior Writer Views

Key orders and briefs were filed this week in state contract pharmacy litigation in Arkansas, Missouri and West Virginia.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two More Drugmakers Partially Exempt Missouri Providers from 340B Contract Pharmacy Restrictions

August 29, 2024 William Newton, Associate Editor/Senior Writer Views

Sanofi joins at least eight other drugmakers that have partially or fully loosened their 340B contract pharmacy restrictions in Missouri.

Drugmakers Sanofi and Sumitoma Pharma America (SMPA) each announced they are partially exempting Missouri-based providers from their contract pharmacy restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

J&J’s Contested 340B Rebate Proposal Would Further Limit Contract Pharmacies, Give Drugmaker More Control of Program, Attorneys Say

August 27, 2024 William Newton, Associate Editor/Senior Writer Views

J&J's plans to convert certain 340B discounts to a rebate model would reshape the 340B program.

Johnson & Johnson’s (J&J’s) proposed 340B rebate model, which has not received government approval, would give the drugmaker significantly more [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live